About the Journal

Focus and Scope

JMIR Cancer (JC, ISSN: 2369-1999, Impact Factor: 2.8) is a peer-reviewed journal focusing on education, innovation and technology in cancer care, cancer survivorship and cancer research, and participatory and patient-centred approaches. This journal also includes research on non-Internet approaches to improve cancer care and cancer research.

We invite submissions of original research, viewpoints, reviews, tutorials, case studies, and non-conventional articles (e.g. open patient education material and software resources that are not yet evaluated but are free for others to use/implement). 

In our "Patients' Corner," we invite patients and survivors to submit short essays and viewpoints on all aspects of cancer. In particular, we are interested in suggestions on improving the health care system and suggestions for new technologies, applications and approaches (this section has no article processing fees).

In 2023, JMIR Cancer received an inaugural Journal Impact Factor™ of 2.8 (Source: Journal Citation Reports™ from Clarivate, 2023). JMIR Cancer is indexed in PubMed Central and PubMedScopusDOAJ, CINAHL, and the Emerging Sources Citation Index (Clarivate)

In case of acceptance, an Article Processing Fee will be charged to cover copyediting and typesetting costs (see fee schedule).